BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ipratropium readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ipratropium\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07394036-3741@assetmemo.bio
DTSTAMP:20261121T004056Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Ipratropium: Phase 2 readout est. (NCT07394036)
DESCRIPTION:Ipratropium\, phase 2.\nStudy: Effect of Ipratropium Bromide on
  EILO\nEstimated primary completion: 31 December 2029. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/ipratropium#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT07394036
URL:https://assetmemo.bio/drug/ipratropium#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
